Class A scavenger receptor deficiency exacerbates lung tumorigenesis by cultivating a procarcinogenic microenvironment in humans and mice.
Abstract
RATIONALE
Genetic alterations on 8p22 have been implicated in multiple cancers, including lung cancer. In this region, genetic variants
of the class A scavenger receptor (SR-A) gene have been associated with prostate cancer risk and have been highlighted as
a potential susceptibility gene of cancer.
OBJECTIVES
To determine whether common polymorphisms in the SR-A gene are associated with human lung cancer risk and to clarify the role
of SR-A in lung carcinogenesis.
METHODS
The relationship of three potentially functional polymorphisms (T-365C, T+25C, and Ala275Pro) in the SR-A gene with lung cancer
risk was evaluated in 1287 lung cancer case subjects and 1261 control subjects from the Chinese population. At the same time,
SR-A null mice were used to investigate its role in lung cancer development.
MEASUREMENTS AND MAIN RESULTS
The T+25C polymorphism was independently associated with lung cancer risk and significantly correlated with decreased expression
of SR-A. The decreased SR-A expression was also found in tumor tissues as compared with normal tissues. Depletion of SR-A
boosted the growth and angiogenesis of implanted Lewis lung carcinoma in mice. The cancer-suppressing capability of SR-A was
attributable to its expression in bone marrow-derived cells as evidenced by bone marrow transplantation. Further analysis
revealed augmented expression of proangiogenic factors including matrix metalloproteinase-9 (MMP9) in SR-A-deficient mice,
indicative of a more procarcinogenic microenvironment. Last, zoledronate, an MMP9 inhibitor, abrogated acceleration of tumor
growth conferred by SR-A loss-of-function.
CONCLUSIONS
Evidence from the population study and mouse model strongly indicates that SR-A may function as a tumor modulator to inhibit
lung cancer growth through affecting the tumor microenvironment.
Links
Authors
Ben J, Jin G, Zhang Y, Ma B, Bai H, Chen J, Zhang H, Gong Q, Zhou X, Zhang H, Qian L, Zhu X, Li X, Yang Q, Hu Z, Xu Y, Shen H, Chen Q
Institution
Atherosclerosis Research Center, Key Laboratory of Cardiovascular Disease and Molecular Intervention, Nanjing Medical University, Nanjing, China.
Source
American journal of respiratory and critical care medicine 186:8 2012 Oct 15 pg 763-72MeSH
AnimalsAsian Continental Ancestry Group
Carcinoma, Lewis Lung
Case-Control Studies
China
Female
Genetic Predisposition to Disease
Humans
Lung Neoplasms
Mice
Mice, Knockout
Polymorphism, Genetic
Scavenger Receptors, Class A
Pub Type(s)
Journal ArticleResearch Support, Non-U.S. Gov't
Language
eng
PubMed ID
22878280
Log In

